Abstract
Background: Previous meta-analysis (Capodanno D, et al, 2012) concluded that in patients with non-valvular atrial fibrillation (NVAF) in world patients, novel oral anticoagulants (NOACs) significantly decreased incidences of all type of stroke and systemic embolism (SE) with similar risk of major bleeding compared to warfarin. But, it is unknown about efficacy and safety of NOACs compared to warfarin in East-Southeast Asian population.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: ASEAN heart journal : Official journal of the ASEAN Federation of Cardiology
Paper Title
Journal
Date
